Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway

被引:171
作者
Weih, F
Caamaño, J
机构
[1] Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany
[2] Univ Birmingham, Sch Med, MRC Ctr Immune Regulat, Dept Immun & Infect, Birmingham, W Midlands, England
关键词
D O I
10.1034/j.1600-065X.2003.00064.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In primary lymphoid organs, such as thymus and bone marrow, B and T lymphocytes differentiate from lymphoid stem cells into mature albeit naive effector cells. In contrast, secondary lymphoid organs, such as the spleen, lymph nodes, and Peyer's patches (PPs), provide an environment that enable lymphocytes to interact with each other, with accessory cells, and with antigens, resulting in the initiation of antigen-specific primary immune responses. Recently, the analysis of gene-knockout mice has shed light on the signaling pathways, cellular requirements, and molecular mechanisms involved in secondary lymphoid organ development. In particular, signals that converge on the nuclear factor-kappaB (NF-kappaB) pathway have been demonstrated to play an important role in both early developmental steps as well as maintenance of secondary lymphoid organ structures. Analysis of the histopathological changes in secondary lymphoid tissues of mice lacking individual Rel/NF-kappaB family members, upstream kinases, and receptors strongly indicates that activation of the recently described alternative NF-kappaB pathway by membrane-bound lymphotoxin, via p52-RelB heterodimers, plays a major role during initiation steps of secondary lymphoid organ development. Induction of the classical p50-RelA NF-kappaB activity, as exemplified by tumor necrosis factor receptor signaling, clearly also contributes, but seems to be involved primarily in later developmental step, such as the proper cellular and structural organization of B-cell follicles.
引用
收藏
页码:91 / 105
页数:15
相关论文
共 113 条
[1]   Three distinctive steps in Peyer's patch formation of murine embryo [J].
Adachi, S ;
Yoshida, H ;
Kataoka, H ;
Nishikawa, S .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (04) :507-514
[2]   Requirement for the NF-κB family member Re1A in the development of secondary lymphoid organs [J].
Alcamo, E ;
Hacohen, N ;
Schulte, LC ;
Rennert, PD ;
Hynes, RO ;
Baltimore, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (02) :233-244
[3]   A chemokine-driven positive feedback loop organizes lymphoid follicles [J].
Ansel, KM ;
Ngo, VN ;
Hyman, PL ;
Luther, SA ;
Förster, R ;
Sedgwick, JD ;
Browning, JL ;
Lipp, M ;
Cyster, JG .
NATURE, 2000, 406 (6793) :309-314
[4]   Chemokines in lymphopoiesis and lymphoid organ development [J].
Ansel, KM ;
Cyster, JG .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (02) :172-179
[5]   Genetic approaches to study Rel/NF-kappa B/I kappa B function in mice [J].
Attar, RM ;
Caamano, J ;
Carrasco, D ;
Iotsova, V ;
Ishikawa, H ;
Ryseck, RP ;
Weih, F ;
Bravo, R .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (02) :93-101
[6]   EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[7]   THE ONCOPROTEIN BCL-3 DIRECTLY TRANSACTIVATES THROUGH KAPPA-B MOTIFS VIA ASSOCIATION WITH DNA-BINDING P50B HOMODIMERS [J].
BOURS, V ;
FRANZOSO, G ;
AZARENKO, V ;
PARK, S ;
KANNO, T ;
BROWN, K ;
SIEBENLIST, U .
CELL, 1993, 72 (05) :729-739
[8]   NF-κB family of transcription factors:: Central regulators of innate and adaptive immune functions [J].
Caamaño, J ;
Hunter, CA .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (03) :414-+
[9]   Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[10]   Nuclear factor κB is required for the development of marginal zone B lymphocytes [J].
Cariappa, A ;
Liou, HC ;
Horwitz, BH ;
Pillai, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08) :1175-1182